Phase 3 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with knee osteoarthritis at a moderate level (known as Kellgren-Lawrence Grade II or III)
- People who have had knee pain for at least three months, with pain occurring on more than half of the days during that time
- People whose pain scores at least 4 out of 10 on a standard pain scale
- People aged between 40 and 75 years old (inclusive)
- Women who have not yet reached menopause must be using two effective forms of birth control that together result in less than a 1% chance of pregnancy per year when used correctly and consistently
- Men must be using an effective form of contraception during the trial
Who may not be able to join:
- People who have had an injection into the knee (such as cortisone, PRP, or hyaluronic acid) within the last three months
- People who are legally or mentally unable to make decisions for themselves (for example, due to Alzheimer's disease or dementia)
- People younger than 40 or older than 75 years of age
- Women who are pregnant or breastfeeding
- Children or people considered vulnerable under research guidelines
- People with a history of cannabis misuse or dependence
- People with blood clotting problems or a history of blood clot-related disease, or whose current blood clotting test results are abnormal
- People who have had a stroke or a serious heart event within the last three months
- People with kidney failure (above a specific level measured by a blood test) or scarring of the liver (cirrhosis)
- People who were taking opioid pain medications just before the start of the study
- People with a known inflammatory type of arthritis, such as rheumatoid arthritis, gout, or pseudogout
- People with a large build-up of fluid in the knee joint
- People with a Body Mass Index (BMI) above 35
- People diagnosed with a major psychiatric illness such as bipolar disorder, as defined by standard diagnostic guidelines
- People diagnosed with major depression, psychosis, or a substance use disorder
- People with a current or past history of thoughts of suicide
- People with abnormal liver function test results
- People with significant liver disease at a moderate or severe level (assessed using a standard medical scoring system)
- People with major neurological conditions such as dementia, Parkinson's disease, epilepsy, cognitive impairment, a history of serious head injury, or seizures
- People taking certain medications that affect how the body processes drugs — including specific enzyme blockers or activators — may be excluded if the treating doctor determines this poses a meaningful clinical concern (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael J Alaia, MD, NYU Langone Health
Phone: 646-501-7223
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
VAS Pain Severity Score; VAS Pain Severity Score; VAS Pain Severity Score; VAS Pain Severity Score; VAS Pain Severity Score; VAS Pain Severity Score; VAS Pain Severity Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.